HR Privacy – Case Law Developments of the Labor Courts and the Belgian DPA (2018-2021)
Webinar | 10.26.21, 11:00 AM CEST - 12:00 PM CEST
In Collaboration with IBJ/IJE
More than 3 years after the go-live of the GDPR, we have a good view on how both the Belgian data protection authority (DPA) and the Belgian courts tackle HR issues from a GDPR point of view.
During this interactive webinar we will walk you through the HR-specific guidance from the Belgian DPA and discuss relevant case law from its Litigation Chamber, the Belgian Market Court as well as from the Belgian labor courts. We will also discuss relevant HR-related decisions from other European data protection authorities, such as the one imposing a € 150,000 fine for relying on employees’ consent for the processing of their personal data.
We will cover specific questions that companies struggle with on a daily basis. Does a global pandemic entitle us to ask my employees for Covid19-related information? Did the GDPR make it illegal to monitor employees? Can I implement an access system based on the employees’ fingerprints? How do companies deal with data subject access requests from (former) employees?
Specific topics will include:
- Processing of employees’ health information in the “new normal”.
- Biometric data of employees: do’s and don’ts.
- Accessing employees’ inboxes during their absence or after their termination.
- Sharing information with colleagues about the termination of an employee.
- Data access rights of (former) employees.
- Retention of employee data.
For more information, please visit these areas: Privacy and Cybersecurity — Brussels Practice, Brussels Practice, European General Data Protection Regulation (GDPR) — Brussels Practice
Contact
Participants
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26
Webinar | 11.13.26
Leveraging the Power of Connection to Better Support our Well-Being


